NADPH oxidases and angiotensin II receptor signaling

[1]  A. Eid,et al.  Nox4 NAD(P)H Oxidase Mediates Src-dependent Tyrosine Phosphorylation of PDK-1 in Response to Angiotensin II , 2008, Journal of Biological Chemistry.

[2]  Ying He,et al.  Redox-Sensitive Signaling by Angiotensin II Involves Oxidative Inactivation and Blunted Phosphorylation of Protein Tyrosine Phosphatase SHP-2 in Vascular Smooth Muscle Cells From SHR , 2008, Circulation research.

[3]  H. Sumimoto.  Structure, regulation and evolution of Nox‐family NADPH oxidases that produce reactive oxygen species , 2008, The FEBS journal.

[4]  D. Shaw,et al.  Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling , 2008, Proceedings of the National Academy of Sciences.

[5]  M. Simionescu,et al.  AP-1–Dependent Transcriptional Regulation of NADPH Oxidase in Human Aortic Smooth Muscle Cells: Role of p22phox Subunit , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[6]  J. Engelhardt,et al.  Evidence for a Superoxide Permeability Pathway in Endosomal Membranes , 2008, Molecular and Cellular Biology.

[7]  D. Pearse,et al.  Angiotensin II increases the expression of the transcription factor ETS-1 in mesangial cells. , 2008, American journal of physiology. Renal physiology.

[8]  R. Arai,et al.  Protein tyrosine phosphorylation and protein tyrosine nitration in redox signaling. , 2008, Antioxidants & redox signaling.

[9]  Yao Sun,et al.  Kidney Fibrosis in Hypertensive Rats: Role of Oxidative Stress , 2008, American Journal of Nephrology.

[10]  R. Touyz,et al.  Renal Redox-Sensitive Signaling, but Not Blood Pressure, Is Attenuated by Nox1 Knockout in Angiotensin II–Dependent Chronic Hypertension , 2008, Hypertension.

[11]  D. Pearse,et al.  Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species. , 2008, American journal of physiology. Renal physiology.

[12]  L. Hunyady,et al.  Mechanism of Angiotensin II-induced Superoxide Production in Cells Reconstituted with Angiotensin Type 1 Receptor and the Components of NADPH Oxidase* , 2008, Journal of Biological Chemistry.

[13]  Ronghua Chen,et al.  ANG II induces c-Jun NH2-terminal kinase activation and proliferation of human mesangial cells via redox-sensitive transactivation of the EGFR. , 2007, American journal of physiology. Renal physiology.

[14]  P. Oettgen,et al.  Ets-1 Is a Critical Transcriptional Regulator of Reactive Oxygen Species and p47phox Gene Expression in Response to Angiotensin II , 2007, Circulation research.

[15]  D. Harrison,et al.  Molecular Mechanisms of Angiotensin II–Mediated Mitochondrial Dysfunction: Linking Mitochondrial Oxidative Damage and Vascular Endothelial Dysfunction , 2007, Circulation research.

[16]  M. Filali,et al.  Cytokine Activation of Nuclear Factor &kgr;B in Vascular Smooth Muscle Cells Requires Signaling Endosomes Containing Nox1 and ClC-3 , 2007, Circulation research.

[17]  R. Webb,et al.  Increased PDZ-RhoGEF/RhoA/Rho kinase signaling in small mesenteric arteries of angiotensin II-induced hypertensive rats , 2007, Journal of hypertension.

[18]  Yan Gao,et al.  Fer-Mediated Cortactin Phosphorylation Is Associated with Efficient Fibroblast Migration and Is Dependent on Reactive Oxygen Species Generation during Integrin-Mediated Cell Adhesion , 2007, Molecular and Cellular Biology.

[19]  Takefumi Mori,et al.  Enhanced Superoxide Production in Renal Outer Medulla of Dahl Salt-Sensitive Rats Reduces Nitric Oxide Tubular-Vascular Cross-Talk , 2007, Hypertension.

[20]  L. Lai,et al.  Angiotensin II Increases Expression of α1C Subunit of L-Type Calcium Channel Through a Reactive Oxygen Species and cAMP Response Element–Binding Protein–Dependent Pathway in HL-1 Myocytes , 2007 .

[21]  B. Morris,et al.  Identification of a Novel Polymorphism in the 3′UTR of the l-Arginine Transporter Gene SLC7A1: Contribution to Hypertension and Endothelial Dysfunction , 2007, Circulation.

[22]  N. Saito,et al.  Subcellular localization and function of alternatively spliced Noxo1 isoforms. , 2007, Free radical biology & medicine.

[23]  W. Welch,et al.  p22phox in the macula densa regulates single nephron GFR during angiotensin II infusion in rats. , 2007, American journal of physiology. Heart and circulatory physiology.

[24]  H. Abboud,et al.  Arachidonic acid-dependent activation of a p22(phox)-based NAD(P)H oxidase mediates angiotensin II-induced mesangial cell protein synthesis and fibronectin expression via Akt/PKB. , 2006, Antioxidants & redox signaling.

[25]  C. Sobey,et al.  Novel isoforms of NADPH-oxidase in cerebral vascular control. , 2006, Pharmacology & therapeutics.

[26]  Ha Won Kim,et al.  Role of Extracellular Superoxide Dismutase in Hypertension , 2006, Hypertension.

[27]  C. Iadecola,et al.  Nox2, Ca2+, and Protein Kinase C Play a Role in Angiotensin II–Induced Free Radical Production in Nucleus Tractus Solitarius , 2006, Hypertension.

[28]  Yihe Wu,et al.  Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy. , 2006, Physiological genomics.

[29]  H. Sumimoto,et al.  Direct Involvement of the Small GTPase Rac in Activation of the Superoxide-producing NADPH Oxidase Nox1* , 2006, Journal of Biological Chemistry.

[30]  R. Busse,et al.  Noxa1 is a central component of the smooth muscle NADPH oxidase in mice. , 2006, Free radical biology & medicine.

[31]  J. Lambeth,et al.  Nox1-dependent Reactive Oxygen Generation Is Regulated by Rac1* , 2006, Journal of Biological Chemistry.

[32]  D. Kwiatkowski,et al.  Requirement of Rac1 in the development of cardiac hypertrophy. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[33]  P. Hordijk.  Regulation of NADPH Oxidases: The Role of Rac Proteins , 2006, Circulation research.

[34]  M. Geiszt,et al.  Involvement of Rac1 in Activation of Multicomponent Nox1- and Nox3-Based NADPH Oxidases , 2006, Molecular and Cellular Biology.

[35]  Z. Ying,et al.  Angiotensin II Up-Regulates the Leukemia-Associated Rho Guanine Nucleotide Exchange Factor (RhoGEF), a Regulator of G Protein Signaling Domain-Containing RhoGEF, in Vascular Smooth Muscle Cells , 2006, Molecular Pharmacology.

[36]  D. Harrison,et al.  RNA Silencing In Vivo Reveals Role of p22phox in Rat Angiotensin Slow Pressor Response , 2006, Hypertension.

[37]  C. Hsieh,et al.  Thioredoxin‐ASK1 complex levels regulate ROS‐mediated p38 MAPK pathway activity in livers of aged and long‐lived Snell dwarf mice , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  K. Krause,et al.  Decreased blood pressure in NOX1‐deficient mice , 2006, FEBS letters.

[39]  Jian-ping Gao,et al.  Activation of AP-1 through reactive oxygen species by angiotensin II in rat cardiomyocytes. , 2005, Free radical biology & medicine.

[40]  D. Pearse,et al.  Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species. , 2005, Kidney international.

[41]  D. Weiss,et al.  Nox1 Overexpression Potentiates Angiotensin II-Induced Hypertension and Vascular Smooth Muscle Hypertrophy in Transgenic Mice , 2005, Circulation.

[42]  H. Matsubara,et al.  Nox1 Is Involved in Angiotensin II–Mediated Hypertension: A Study in Nox1-Deficient Mice , 2005, Circulation.

[43]  K. Hsu,et al.  NADPH Oxidase–Derived Superoxide Anion Mediates Angiotensin II–Induced Pressor Effect via Activation of p38 Mitogen–Activated Protein Kinase in the Rostral Ventrolateral Medulla , 2005, Circulation research.

[44]  H. Katus,et al.  Angiotensin II Stimulates Matrix Metalloproteinase Secretion in Human Vascular Smooth Muscle Cells via Nuclear Factor-κB and Activator Protein 1 in a Redox-Sensitive Manner , 2005, Journal of Vascular Research.

[45]  P. Lévy,et al.  Angiotensin II induces tyrosine nitration and activation of ERK1/2 in vascular smooth muscle cells , 2005, FEBS letters.

[46]  P. Oettgen,et al.  Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. , 2005, The Journal of clinical investigation.

[47]  R. Alexander,et al.  Caveolin-1 Is Essential for Activation of Rac1 and NAD(P)H Oxidase After Angiotensin II Type 1 Receptor Stimulation in Vascular Smooth Muscle Cells: Role in Redox Signaling and Vascular Hypertrophy , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[48]  H. Nawata,et al.  Statin attenuates high glucose-induced and angiotensin II-induced MAP kinase activity through inhibition of NAD(P)H oxidase activity in cultured mesangial cells. , 2005, Medicinal chemistry (Shariqah (United Arab Emirates)).

[49]  N. Tonks.  Redox Redux: Revisiting PTPs and the Control of Cell Signaling , 2005, Cell.

[50]  M. Rohde,et al.  Cellular invasion by Staphylococcus aureus reveals a functional link between focal adhesion kinase and cortactin in integrin-mediated internalisation , 2005, Journal of Cell Science.

[51]  D. Barford,et al.  Functions and mechanisms of redox regulation of cysteine-based phosphatases. , 2005, Antioxidants & redox signaling.

[52]  Kunihiro Matsumoto,et al.  ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity , 2005, Nature Immunology.

[53]  Lie Gao,et al.  Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM. , 2005, American journal of physiology. Heart and circulatory physiology.

[54]  M. Raizada,et al.  NAD(P)H Oxidase Inhibition Attenuates Neuronal Chronotropic Actions of Angiotensin II , 2005, Circulation research.

[55]  M. Zimmerman,et al.  Superoxide Mediates Angiotensin II–Induced Influx of Extracellular Calcium in Neural Cells , 2005, Hypertension.

[56]  R. Touyz,et al.  Angiotensin II-Dependent Chronic Hypertension and Cardiac Hypertrophy Are Unaffected by gp91phox-Containing NADPH Oxidase , 2005, Hypertension.

[57]  E. Schiffrin,et al.  p47phox Associates With the Cytoskeleton Through Cortactin in Human Vascular Smooth Muscle Cells: Role in NAD(P)H Oxidase Regulation by Angiotensin II , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[58]  D. Kaye,et al.  Impaired l-Arginine Transport and Endothelial Function in Hypertensive and Genetically Predisposed Normotensive Subjects , 2004, Circulation.

[59]  Kap-Seok Yang,et al.  Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[60]  Lie Gao,et al.  Superoxide Mediates Sympathoexcitation in Heart Failure: Roles of Angiotensin II and NAD(P)H Oxidase , 2004, Circulation research.

[61]  J. Engelhardt,et al.  Requirement for Rac1-Dependent NADPH Oxidase in the Cardiovascular and Dipsogenic Actions of Angiotensin II in the Brain , 2004, Circulation research.

[62]  E. Schiffrin,et al.  Differential Calcium Regulation by Hydrogen Peroxide and Superoxide in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats , 2004, Journal of cardiovascular pharmacology.

[63]  R. Alexander,et al.  Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cells. , 2004, American journal of physiology. Cell physiology.

[64]  M. Zimmerman,et al.  Hypertension Caused by Angiotensin II Infusion Involves Increased Superoxide Production in the Central Nervous System , 2004, Circulation research.

[65]  H. Abboud,et al.  Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells. , 2004, The Biochemical journal.

[66]  E. Schiffrin,et al.  Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells , 2004, Journal of Hypertension.

[67]  K. Griendling,et al.  Distinct Subcellular Localizations of Nox1 and Nox4 in Vascular Smooth Muscle Cells , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[68]  H. Motoshima,et al.  The NAD(P)H Oxidase Homolog Nox4 Modulates Insulin-Stimulated Generation of H2O2 and Plays an Integral Role in Insulin Signal Transduction , 2004, Molecular and Cellular Biology.

[69]  M. Haque,et al.  Assessment of Renal Functional Phenotype in Mice Lacking gp91PHOX Subunit of NAD(P)H Oxidase , 2004, Hypertension.

[70]  G. Salido,et al.  Effect of hydrogen peroxide on Ca2+ mobilisation in human platelets through sulphydryl oxidation dependent and independent mechanisms. , 2004, Biochemical pharmacology.

[71]  F. Fenoy,et al.  Role of Superoxide in Modulating the Renal Effects of Angiotensin II , 2003, Hypertension.

[72]  D. Gutterman,et al.  Mechanism of dilation to reactive oxygen species in human coronary arterioles. , 2003, American journal of physiology. Heart and circulatory physiology.

[73]  T. Cheng,et al.  Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. , 2003, Journal of the American College of Cardiology.

[74]  S. Aslam,et al.  Role of oxidative stress in endothelial dysfunction and enhanced responses to angiotensin II of afferent arterioles from rabbits infused with angiotensin II. , 2003, Journal of the American Society of Nephrology : JASN.

[75]  A. Takeshita,et al.  Long-Term Inhibition of Rho-Kinase Suppresses Angiotensin II–Induced Cardiovascular Hypertrophy in Rats In Vivo: Effect on Endothelial NAD(P)H Oxidase System , 2003, Circulation research.

[76]  C. Downes,et al.  Redox regulation of PI 3‐kinase signalling via inactivation of PTEN , 2003, The EMBO journal.

[77]  Takefumi Mori,et al.  Angiotensin II–NAD(P)H Oxidase–Stimulated Superoxide Modifies Tubulovascular Nitric Oxide Cross-Talk in Renal Outer Medulla , 2003, Hypertension.

[78]  A. Takeshita,et al.  Cyclic AMP Response Element–Binding Protein Mediates Reactive Oxygen Species–Induced c-fos Expression , 2003, Hypertension.

[79]  H. Abboud,et al.  Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. , 2003, American journal of physiology. Renal physiology.

[80]  L. Khachigian,et al.  Ets-1 Protects Vascular Smooth Muscle Cells from Undergoing Apoptosis by Activating p21WAF1/Cip1 , 2003, Journal of Biological Chemistry.

[81]  S. Aslam,et al.  Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[82]  E. Schiffrin,et al.  c-Src Induces Phosphorylation and Translocation of p47phox: Role in Superoxide Generation by Angiotensin II in Human Vascular Smooth Muscle Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[83]  T. Leto,et al.  Proteins Homologous to p47phox and p67phox Support Superoxide Production by NAD(P)H Oxidase 1 in Colon Epithelial Cells* , 2003, Journal of Biological Chemistry.

[84]  J. Zweier,et al.  Hypertension caused by transgenic overexpression of Rac1. , 2003, Antioxidants & redox signaling.

[85]  M. Jankowski,et al.  NAD(P)H Oxidase Mediates Angiotensin II–Induced Vascular Macrophage Infiltration and Medial Hypertrophy , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[86]  D. Hartshorne,et al.  Activation of RhoA and Inhibition of Myosin Phosphatase as Important Components in Hypertension in Vascular Smooth Muscle , 2003, Circulation research.

[87]  Takashi Saito,et al.  Role for Hydrogen Peroxide in Flow-Induced Dilation of Human Coronary Arterioles , 2003, Circulation research.

[88]  K. Krause,et al.  Two Novel Proteins Activate Superoxide Generation by the NADPH Oxidase NOX1* , 2003, The Journal of Biological Chemistry.

[89]  E. Schiffrin,et al.  Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation. , 2003, Canadian journal of physiology and pharmacology.

[90]  D. Rodríguez‐Puyol,et al.  Angiotensin II induces a rapid and transient increase of reactive oxygen species. , 2002, Antioxidants & redox signaling.

[91]  P. Singhal,et al.  Angiotensin II-Induced Mesangial Cell Apoptosis: Role of Oxidative Stress , 2002, Molecular medicine.

[92]  D. Spitz,et al.  Superoxide Mediates the Actions of Angiotensin II in the Central Nervous System , 2002, Circulation research.

[93]  Hua Cai,et al.  Role of p47phox in Vascular Oxidative Stress and Hypertension Caused by Angiotensin II , 2002, Hypertension.

[94]  Jerónimo Bravo,et al.  Binding of the PX domain of p47phox to phosphatidylinositol 3,4‐bisphosphate and phosphatidic acid is masked by an intramolecular interaction , 2002, The EMBO journal.

[95]  P. Seshiah,et al.  Angiotensin II Stimulation of NAD(P)H Oxidase Activity: Upstream Mediators , 2002, Circulation research.

[96]  G. Nickenig,et al.  Redox‐sensitive vascular smooth muscle cell proliferation is mediated by GKLF and Id3 in vitro and in vivo , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[97]  E. Schiffrin,et al.  Expression of a Functionally Active gp91phox-Containing Neutrophil-Type NAD(P)H Oxidase in Smooth Muscle Cells From Human Resistance Arteries: Regulation by Angiotensin II , 2002, Circulation research.

[98]  Woojin Jeong,et al.  Reversible Inactivation of the Tumor Suppressor PTEN by H2O2 * , 2002, The Journal of Biological Chemistry.

[99]  T. Finkel,et al.  Redox Regulation of Cdc25C* , 2002, The Journal of Biological Chemistry.

[100]  K. Takeda,et al.  Critical Role of cAMP-response Element-binding Protein for Angiotensin II-induced Hypertrophy of Vascular Smooth Muscle Cells* , 2002, The Journal of Biological Chemistry.

[101]  D. Gutterman,et al.  Oxidative Stress And Potassium Channel Function , 2002, Clinical and experimental pharmacology & physiology.

[102]  U. Walter,et al.  Effects of Angiotensin II Infusion on the Expression and Function of NAD(P)H Oxidase and Components of Nitric Oxide/cGMP Signaling , 2002, Circulation research.

[103]  H. Schmidt,et al.  Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. , 2001, Free radical biology & medicine.

[104]  M. Suematsu,et al.  ERK and p38 MAPK, but not NF-&kgr;B, Are Critically Involved in Reactive Oxygen Species–Mediated Induction of IL-6 by Angiotensin II in Cardiac Fibroblasts , 2001, Circulation research.

[105]  M. Yoshizumi,et al.  Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells. , 2001, Molecular pharmacology.

[106]  H. Piper,et al.  Redox‐sensitve intermediates mediate angiotensin II‐induced p38 MAP kinase activation, AP‐1 binding activity, and TGF‐β expression in adult ventricular cardiomyocytes , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[107]  H. Abboud,et al.  Angiotensin II activates Akt/protein kinase B by an arachidonic acid/redox‐dependent pathway and independent of phosphoinositide 3‐kinase , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[108]  R. Busse,et al.  Thrombin Activates the Hypoxia-Inducible Factor-1 Signaling Pathway in Vascular Smooth Muscle Cells: Role of the p22phox-Containing NADPH Oxidase , 2001, Circulation research.

[109]  S. Holland,et al.  Genetic Demonstration of p47phox-Dependent Superoxide Anion Production in Murine Vascular Smooth Muscle Cells , 2001, Circulation.

[110]  D. Johns,et al.  Role of NADPH Oxidase in the Vascular Hypertrophic and Oxidative Stress Response to Angiotensin II in Mice , 2001, Circulation research.

[111]  D. Sorescu,et al.  Novel gp91phox Homologues in Vascular Smooth Muscle Cells: nox1 Mediates Angiotensin II-Induced Superoxide Formation and Redox-Sensitive Signaling Pathways , 2001, Circulation research.

[112]  M. Yoshizumi,et al.  Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells. , 2001, Hypertension research : official journal of the Japanese Society of Hypertension.

[113]  P. L. Becker,et al.  Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[114]  E. Schiffrin,et al.  Role of c-Src in the regulation of vascular contraction and Ca2+ signaling by angiotensin II in human vascular smooth muscle cells , 2001, Journal of hypertension.

[115]  L. Hunyady,et al.  Beta-arrestin- and dynamin-dependent endocytosis of the AT1 angiotensin receptor. , 2001, Molecular pharmacology.

[116]  P. Várnai,et al.  Identification of renox, an NAD(P)H oxidase in kidney. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[117]  Yuji Saito,et al.  Angiotensin II Induces Transactivation of Two Different Populations of the Platelet-derived Growth Factor β Receptor , 2000, The Journal of Biological Chemistry.

[118]  C. Elsing,et al.  Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[119]  D. Harrison,et al.  Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. , 2000, Circulation research.

[120]  A. Somlyo,et al.  Signal transduction by G‐proteins, Rho‐kinase and protein phosphatase to smooth muscle and non‐muscle myosin II , 2000, The Journal of physiology.

[121]  B. T. Altura,et al.  Hydrogen peroxide induces contraction and raises [Ca2+]i in canine cerebral arterial smooth muscle: participation of cellular signaling pathways , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[122]  J. Egido,et al.  Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. , 1999, Atherosclerosis.

[123]  E. Schiffrin,et al.  Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. , 1999, Hypertension.

[124]  R. Alexander,et al.  Reactive Oxygen Species Mediate the Activation of Akt/Protein Kinase B by Angiotensin II in Vascular Smooth Muscle Cells* , 1999, The Journal of Biological Chemistry.

[125]  Y. Mori,et al.  Angiotensin II-induced transactivation of epidermal growth factor receptor regulates fibronectin and transforming growth factor-beta synthesis via transcriptional and posttranscriptional mechanisms. , 1999, Circulation research.

[126]  E. Schiffrin,et al.  Role of extracellular signal-regulated kinases in angiotensin II-stimulated contraction of smooth muscle cells from human resistance arteries. , 1999, Circulation.

[127]  G. Ramponi,et al.  The Inactivation Mechanism of Low Molecular Weight Phosphotyrosine-protein Phosphatase by H2O2 * , 1998, The Journal of Biological Chemistry.

[128]  R. Alexander,et al.  Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. , 1998, Circulation research.

[129]  Richard E. White,et al.  Hydrogen peroxide relaxes porcine coronary arteries by stimulating BKCachannel activity. , 1998, American journal of physiology. Heart and circulatory physiology.

[130]  E. Jaimes,et al.  Angiotensin II induces superoxide anion production by mesangial cells. , 1998, Kidney international.

[131]  R. Alexander,et al.  Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. , 1998, Hypertension.

[132]  B. T. Altura,et al.  Mechanisms of hydrogen peroxide-induced contraction of rat aorta. , 1998, European journal of pharmacology.

[133]  G. Callis,et al.  Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[134]  W. R. Taylor,et al.  Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats. , 1997, Hypertension.

[135]  Shuh Narumiya,et al.  Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension , 1997, Nature.

[136]  N. Jin,et al.  Activation of tyrosine kinases in H2O2-induced contraction in pulmonary artery. , 1997, The American journal of physiology.

[137]  L. Ghiadoni,et al.  Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. , 1996, Circulation.

[138]  J S Beckman,et al.  Mechanisms of cerebral vasodilation by superoxide, hydrogen peroxide, and peroxynitrite. , 1996, The American journal of physiology.

[139]  D. Harrison,et al.  Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. , 1996, The Journal of clinical investigation.

[140]  M. Karin,et al.  Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation , 1996, Molecular and cellular biology.

[141]  T. Maniatis,et al.  Site-Specific Phosphorylation of IκBα by a Novel Ubiquitination-Dependent Protein Kinase Activity , 1996, Cell.

[142]  M. Karin,et al.  Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B , 1995, Molecular and cellular biology.

[143]  P. R. Gardner,et al.  Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[144]  R W Alexander,et al.  Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. , 1994, Circulation research.

[145]  M. Wolin,et al.  Hydrogen peroxide-induced pulmonary vasodilation: role of guanosine 3',5'-cyclic monophosphate. , 1991, The American journal of physiology.

[146]  S. Wilson,et al.  Role of oxygen-derived free radicals in acute angiotensin II--induced hypertensive vascular disease in the rat. , 1990, Circulation research.

[147]  M. Wolin,et al.  Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. , 1987, The American journal of physiology.

[148]  R. Alexander,et al.  Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. , 1986, The Journal of biological chemistry.

[149]  L. Shang,et al.  NF-kappaB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II. , 2008, American journal of physiology. Cell physiology.

[150]  K. Krause,et al.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. , 2007, Physiological reviews.

[151]  M. Dinauer,et al.  Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. , 2006, Cellular signalling.

[152]  L. Navar,et al.  Enhanced superoxide generation modulates renal function in ANG II-induced hypertensive rats. , 2006, American journal of physiology. Renal physiology.

[153]  D. Harrison,et al.  Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. , 2005, American journal of physiology. Heart and circulatory physiology.

[154]  W. Welch,et al.  Angiotensin-induced defects in renal oxygenation: role of oxidative stress. , 2005, American journal of physiology. Heart and circulatory physiology.

[155]  G. Kojda,et al.  Hemodynamic and biochemical adaptations to vascular smooth muscle overexpression of p22phox in mice. , 2005, American journal of physiology. Heart and circulatory physiology.

[156]  J. Vijg,et al.  Reduction of pressor response to vasoconstrictor agents by overexpression of catalase in mice. , 2003, American journal of hypertension.

[157]  R. Brandes,et al.  Role of p22phox in angiotensin II and platelet-derived growth factor AA induced activator protein 1 activation in vascular smooth muscle cells , 2003, Journal of Molecular Medicine.

[158]  D. Rodríguez‐Puyol,et al.  The role of hydrogen peroxide in the contractile response to angiotensin II. , 2001, Molecular pharmacology.

[159]  T. Yamakawa,et al.  Involvement of reactive oxygen species in the activation of tyrosine kinase and extracellular signal-regulated kinase by angiotensin II. , 2000, Endocrinology.

[160]  R. Ardaillou,et al.  Mesangial AT1 receptors: expression, signaling, and regulation. , 1999, Journal of the American Society of Nephrology : JASN.

[161]  T. Meinertz,et al.  Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. , 1999, Kidney international.

[162]  M. Ushio-Fukai,et al.  Arachidonic acid metabolites mediate angiotensin II-induced NADH/NADPH oxidase activity and hypertrophy in vascular smooth muscle cells. , 1999, Antioxidants & redox signaling.

[163]  G. Wolf,et al.  Angiotensin II-mediated expression of p27Kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals. , 1998, Kidney international.

[164]  S. Rajagopalan,et al.  p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. , 1997, Circulation research.

[165]  T. Maniatis,et al.  Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. , 1996, Cell.

[166]  M. Phillips.  Functions of angiotensin in the central nervous system. , 1987, Annual review of physiology.

[167]  Phillips Mi.  Functions of Angiotensin in the Central Nervous System , 1987 .